Nuvectis Pharma, Inc. (NVCT) stock forecast and price target
Price $20.24 · data as of November 13, 2026
12-month price target
Average target$35.40
Upside / downside+74.9%
Analysts5
ConsensusStrong buy
Low $30.00Average $35.40High $40.00
Gold marker: average target · white marker: today’s price ($20.24)
Analyst ratings
Strong buy 2Buy 4Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.03 | — | $0 |
| Next fiscal year ends December 31, 2027 | $-1.70 | — | $0 |
| Next quarter ends December 31, 2026 | $-0.37 | — | $0 |
| Quarter after ends March 31, 2027 | $-0.28 | — | $0 |
Consensus of the analysts covering Nuvectis Pharma, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.
Frequently asked questions
What is the Nuvectis Pharma stock price target?
The average 12-month target from 5 analysts is $35.40, 74.9% above the current price of $20.24 Targets range from $30.00 to $40.00.
Is Nuvectis Pharma a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 4 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Nuvectis Pharma expected to earn?
Analysts expect EPS of $-2.03 for the fiscal year ending December 31, 2026 and $-1.70 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.